138 related articles for article (PubMed ID: 12878211)
1. Expression of erythropoietin receptor splice variants in human cancer.
Arcasoy MO; Jiang X; Haroon ZA
Biochem Biophys Res Commun; 2003 Aug; 307(4):999-1007. PubMed ID: 12878211
[TBL] [Abstract][Full Text] [Related]
2. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
3. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
[TBL] [Abstract][Full Text] [Related]
4. Functional significance of erythropoietin receptor expression in breast cancer.
Arcasoy MO; Amin K; Karayal AF; Chou SC; Raleigh JA; Varia MA; Haroon ZA
Lab Invest; 2002 Jul; 82(7):911-8. PubMed ID: 12118093
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells.
Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Macejová M; Košuth J; Zulli A; Debeljak N; Hudler P; Jašek K; Kašubová I; Kubatka P; Solár P
BMC Genet; 2019 Jan; 20(1):1. PubMed ID: 30606107
[TBL] [Abstract][Full Text] [Related]
7. Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia.
Motohashi T; Nakamura Y; Osawa M; Hiroyama T; Iwama A; Shibuya A; Nakauchi H
Eur J Haematol; 2001 Aug; 67(2):88-93. PubMed ID: 11722595
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.
Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S
Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and erythropoietin receptor expression in human cancer.
Acs G; Acs P; Beckwith SM; Pitts RL; Clements E; Wong K; Verma A
Cancer Res; 2001 May; 61(9):3561-5. PubMed ID: 11325818
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture.
Nagai A; Nakagawa E; Choi HB; Hatori K; Kobayashi S; Kim SU
J Neuropathol Exp Neurol; 2001 Apr; 60(4):386-92. PubMed ID: 11305874
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin receptor spliced forms differentially expressed in blind subterranean mole rats.
Shams I; Nevo E; Avivi A
FASEB J; 2005 Oct; 19(12):1749-51. PubMed ID: 16081499
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
[TBL] [Abstract][Full Text] [Related]
14. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
Gombos Z; Danihel L; Repiska V; Acs G; Furth E
Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
[TBL] [Abstract][Full Text] [Related]
15. Characterization of three erythropoietin (Epo)-binding proteins in various human Epo-responsive cell lines and in cells transfected with human Epo-receptor cDNA.
Takahashi T; Chiba S; Hirano N; Yazaki Y; Hirai H
Blood; 1995 Jan; 85(1):106-14. PubMed ID: 7803787
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A
Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679
[TBL] [Abstract][Full Text] [Related]
17. Lack of functional erythropoietin receptors of cancer cell lines.
Laugsch M; Metzen E; Svensson T; Depping R; Jelkmann W
Int J Cancer; 2008 Mar; 122(5):1005-11. PubMed ID: 17990315
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
[TBL] [Abstract][Full Text] [Related]
19. Structural and biological properties of erythropoietin in Xenopus laevis.
Nogawa-Kosaka N; Hirose T; Kosaka N; Aizawa Y; Nagasawa K; Uehara N; Miyazaki H; Komatsu N; Kato T
Exp Hematol; 2010 May; 38(5):363-72. PubMed ID: 20193733
[TBL] [Abstract][Full Text] [Related]
20. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
